References for: OBJECT

Full identifier: http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
complications
Eva Zegelaar
2021-12-16T20:12:31.441Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
complications
Eva Zegelaar
2021-12-16T20:02:19.221Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
male
Eva Zegelaar
2021-12-16T20:02:17.822Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )
Eva Zegelaar
2021-12-16T19:56:19.128Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )
Eva Zegelaar
2021-12-16T19:56:17.762Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )
Eva Zegelaar
2021-12-16T19:56:16.425Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
with usual care or placebo ( 3 trials , 1282 patients , and 527 deaths )
Eva Zegelaar
2021-12-16T19:56:15.093Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:51.646Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:50.017Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:48.147Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:46.567Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:44.766Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:43.051Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:41.596Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:40.109Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:38.644Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:54:37.099Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
mortality
Eva Zegelaar
2021-12-16T19:54:26.723Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
improvement
Eva Zegelaar
2021-12-16T19:52:08.923Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
improvement
Eva Zegelaar
2021-12-16T19:52:07.410Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:51:12.606Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:51:08.630Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:51:05.679Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:51:00.273Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:56.063Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:52.649Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:51.051Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:49.103Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:47.682Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:45.887Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:44.523Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:43.061Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:41.422Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a statistically significant decrease in mortality ( HR ) = 0.087 95 % CI 0.021-0.36
Eva Zegelaar
2021-12-16T19:50:39.759Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:38.159Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:35.485Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:33.839Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:31.711Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:29.090Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
a significantly lower rate of severe COVID-19compared to the control group ( 75.9 % vs 40.0 % , P-value=0.012 )
Eva Zegelaar
2021-12-16T19:50:26.769Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:25.153Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:23.282Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:21.725Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:20.357Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:18.844Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
benefit in patients with coronavirus disease 2019 ( COVID)-19 )
Eva Zegelaar
2021-12-16T19:50:17.191Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:15.299Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:13.652Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:12.259Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:10.385Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:08.819Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
for prolonged periods of time
Eva Zegelaar
2021-12-16T19:50:07.184Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:50:05.331Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:50:03.487Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:50:02.212Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:50:00.950Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:59.655Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:58.377Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:57.091Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:55.821Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:54.529Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:53.267Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:51.973Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:50.713Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:49.413Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:48.134Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:46.811Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:45.347Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:43.996Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:42.658Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:41.339Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:39.970Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:38.645Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:37.320Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:36.006Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
that AA ( arachidonic acid ) is most suited for such preventive and therapeutic approach
Eva Zegelaar
2021-12-16T19:49:34.667Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:33.328Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:31.995Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:30.646Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:29.304Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:27.968Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:26.642Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:25.340Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:24.030Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:22.530Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
significant protection against mortality ( single study )
Eva Zegelaar
2021-12-16T19:49:21.198Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:19.874Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:18.097Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:16.356Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:15.020Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:13.371Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:12.051Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:10.745Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
clinical effectivenessin severe COVID-19 in hospitalized patients
Eva Zegelaar
2021-12-16T19:49:09.442Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:08.133Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:06.803Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:05.469Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:04.140Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:02.834Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
OBJECT
( two-tailed p < 0.001 ) from the first month of COVID-19 pandemic to the second month
Eva Zegelaar
2021-12-16T19:49:01.526Z
Showing 1 to 100 of 1000
<< 1 2 3 4 5 6 7 8 9 10 >>